Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Squamous Cell

Explore clinical trials studying Neoplasms, Squamous Cell. Study availability and eligibility vary by location and protocol.

815 public trials 209 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Squamous Cell trial results

Completed

Rigosertib for RDEB-SCC

NCT03786237

Conditions
Carcinoma, Carcinoma, Squamous Cell, Collagen Diseases, +16 more
Locations
  • EB House Austria/Dept. of Dermatology University Hospital Salzburg, State of Salzburg, Austria
View Trial Details
Completed

Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC.

NCT05142709

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • The 2nd affiliated hospital of Bengbu medical University Bengbu, Anhui, China
  • The 2nd people's hospital of Anhui province Hefei, Anhui, China
  • Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou, Fujian, China
  • The 1st affiliated hospital of Xiamen University Xiamen, Fujian, China
View all 23 locations
View Trial Details
Completed

Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma

NCT02131805

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cutaneous Basal Cell, +5 more
Locations
  • Boca Raton Regional Hospital Boca Raton, Florida, United States
  • Memorial Sloan Kettering Basking Ridge (Consent only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent only) Montvale, New Jersey, United States
View Trial Details
Completed

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

NCT04045496

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
Locations
  • HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States
  • Tennessee Oncology, PLLC Nashville, Tennessee, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
  • Washington University School of Medicine Seattle, Washington, United States
View Trial Details
Completed

A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)

NCT05342636

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • Liga Norte Riograndense Contra o Câncer ( Site 2303) Natal, Rio Grande do Norte, Brazil
  • Hospital Nossa Senhora da Conceição ( Site 2301) Porto Alegre, Rio Grande do Sul, Brazil
  • ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 2300) São Paulo, Brazil
  • FALP-UIDO ( Site 2400) Santiago, Region M. de Santiago, Chile
View all 46 locations
View Trial Details

Related conditions